Trigonelline (Pyridine Alkaloid · Antidiabetic · NAD+ Precursor Research)

Compound	Trigonelline
Chemical class	Alkaloid — Pyridine (N-Methylnicotinic Acid Betaine)
CAS	535-83-1
Primary source	Trigonella foenum-graecum (fenugreek), Coffea arabica (coffee), Humulus lupulus (hops)
Key applications	Antidiabetic, neuroprotective, anti-migraine, NAD+ precursor research
Claim strength	Moderate
Typical form	Fenugreek extract co-constituent; coffee roasting by-product; isolated trigonelline
Buy from Herbuno	Fenugreek Seed Extract Powder | Methi → Fenugreek Leaf Extract Powder - Trigonella foenum-graecum | Methi →

Commercial source: Trigonelline is commercially available as a co-constituent of fenugreek (Trigonella foenum-graecum) seed extract. Fenugreek seed extracts standardised to saponins, 4-hydroxyisoleucine, or total alkaloids all co-deliver trigonelline. See sourcing options below. Traditional use: Fenugreek (Methi in Ayurveda, Hu Lu Ba in TCM) is one of the oldest medicinal and culinary plants, used across India, Egypt, and the Mediterranean for over 4,000 years for diabetes management, digestive complaints, lactation promotion, and as an aphrodisiac tonic. Trigonelline was identified as a key bioactive alongside the saponins and 4-hydroxyisoleucine in fenugreek’s antidiabetic activity profile. Research trajectory: Trigonelline has attracted research for antidiabetic (beta-cell protection, alpha-glucosidase inhibition), neuroprotective (axon regeneration promotion), and NAD+ precursor mechanisms. Coffee provides the largest dietary trigonelline exposure for most populations; roasting converts trigonelline to niacin (vitamin B3), with green coffee retaining full trigonelline content. See sourcing options below.

---

Evidence for Trigonelline Applications

Antidiabetic — beta-cell protection and glucose lowering: Trigonelline stimulates insulin secretion, inhibits alpha-glucosidase, and protects pancreatic beta-cells from oxidative stress in multiple animal diabetic models. Human fenugreek RCTs showing blood glucose reduction are partly attributed to trigonelline alongside saponins and 4-hydroxyisoleucine. Claim strength: Moderate (preclinical mechanism well-characterised; human attribution to trigonelline specifically is indirect).

Neuroprotective — axon regeneration: Trigonelline promotes axon regeneration and neuronal survival after injury in cell and animal models, via NF-κB inhibition and Nrf2 activation. This is a mechanistically differentiated neuroprotective profile — promoting recovery rather than only preventing degeneration. Claim strength: Moderate.

NAD+ precursor research: Trigonelline has been proposed as a novel NAD+ precursor pathway (independent of NMN/NR pathways) via pyridine ring metabolism. Recent research suggests trigonelline supplementation can increase muscle NAD+ levels in animal models, with preliminary human correlational data from coffee consumption and NAD+ status. This is an emerging application area. Claim strength: Emerging.

---

Dosage & Formulator Specification

No established isolated human supplement dose for trigonelline. Fenugreek seed extract at 500–1000 mg/day (standardised to saponins or 4-hydroxyisoleucine) co-delivers trigonelline as a constituent. For trigonelline-specific activity, green coffee extract (high in trigonelline before roasting destroys it — approximately 1% trigonelline by dry weight) provides meaningful trigonelline alongside chlorogenic acids. Isolated trigonelline is available from specialist chemical suppliers for research formulation.

Important: roasting coffee degrades trigonelline to nicotinic acid and pyridines — roasted coffee contains much less trigonelline than green coffee. For trigonelline-targeted formulations, green coffee extract (not roasted coffee extract) is the appropriate coffee-based source.

---

Frequently Asked Questions — Trigonelline

Is trigonelline a form of niacin (vitamin B3)?
Trigonelline (N-methylnicotinic acid betaine) is structurally related to nicotinic acid (niacin) — it is nicotinic acid with an N-methyl group added (making it a betaine/quaternary nitrogen compound). Upon thermal degradation (roasting coffee) or metabolic transformation, trigonelline can yield nicotinic acid. However, trigonelline itself is not a form of niacin in terms of vitamin activity — it requires demethylation to release nicotinic acid. Intact trigonelline has its own pharmacological profile distinct from niacin.

Why does coffee roasting destroy trigonelline?
Trigonelline undergoes thermal pyrolysis at roasting temperatures (180–230°C), converting to nicotinic acid (via demethylation and decarboxylation) and various pyridine derivatives. This conversion is both a loss of trigonelline content and a gain of nicotinic acid (which contributes to coffee’s niacin content). Light roasts retain more trigonelline than dark roasts; green (unroasted) beans have the highest trigonelline content. This parallels chlorogenic acid degradation during roasting.

Is the NAD+ precursor mechanism for trigonelline established?
This is a newly described pathway (published ~2023) showing trigonelline can enter NAD+ biosynthesis via a pyridine ring modification pathway in muscle tissue. Animal and observational human data are promising but the pathway has not been validated in human interventional trials at the time of writing. This positions trigonelline as an exciting emerging ingredient alongside NMN and NR in the NAD+ longevity supplement space, but with less developed clinical evidence than those established NAD+ precursors.

Can fenugreek extract be specified for trigonelline content?
Fenugreek extract is most commonly standardised to saponins (40–60%) or 4-hydroxyisoleucine (40%) for metabolic health applications, with trigonelline as an unstandardised co-constituent. For trigonelline-specific formulation intent, request HPLC trigonelline quantification alongside standard saponin content on the CoA. The absolute trigonelline content in commercial fenugreek seed extract varies by variety and processing; typical range is 0.1–0.5% trigonelline by dry extract weight.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery